For clinical development teams: AI implementation, protocol review, competitive trial analysis, regulatory updates — practical how-tos, not concepts.
How clinical development teams should choose their first AI tasks: checkable outputs, defined sources, acceptance criteria, and scope discipline.
Read →A positive Phase III readout changes the landscape but not the decision: separate statistical success from clinical value, and turn new evidence into actions.
Read →How to use AI to compare eligibility criteria across trials while keeping original wording, AND/OR logic, exceptions, and visible uncertainty.
Read →Five connections to check first when reviewing an AI-written clinical protocol: research question, population, treatment, endpoints, and safety.
Read →A practical guide to turning the ten shared FDA–EMA good AI practice principles into everyday drug development work.
Read →Which AI uses in clinical development are worth serious testing: evidence retrieval, criterion-level assistance, and document consistency checks.
Read →A small public-material test comparing three lung-cancer trials shows what AI-assisted fixed-field extraction can leave out.
Read →How to turn a clinical paper into development decisions: separate observation from inference, and make transfer assumptions explicit.
Read →How to professionally review an AI-written study synopsis: input basis, design alternatives, eligibility, safety, and a decision table.
Read →Ten questions to ask before adopting a clinical development AI tool, covering sources, evidence, errors, review cost, data, and regulatory status.
Read →A practical first AI workflow for Chinese clinical development teams: a sourced design matrix in one indication.
Read →Visit "AI for You" to see how AI helps patients find suitable clinical trials.
See AI for You →